Zealand Pharma A/S
ZLDPF
$54.00
$0.480.90%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.22M | 10.74M | 7.76M | 1.38B | 1.13M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.22M | 10.74M | 7.76M | 1.38B | 1.13M |
| Cost of Revenue | -- | 0.00 | -- | 62.40K | -- |
| Gross Profit | 5.22M | 10.74M | 7.76M | 1.38B | 1.13M |
| SG&A Expenses | 15.97M | 14.31M | 29.90M | 16.80M | 14.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 200.00 | -- | 26.60M | 3.10M |
| Total Operating Expenses | 87.98M | 96.93M | 80.03M | 114.06M | 58.40M |
| Operating Income | -82.76M | -86.19M | -72.26M | 1.27B | -57.27M |
| Income Before Tax | -60.50M | -63.36M | -57.45M | 1.23B | -47.40M |
| Income Tax Expenses | -- | -4.27M | 5.87M | 81.73M | -141.10K |
| Earnings from Continuing Operations | -60.50M | -59.09M | -63.32M | 1.15B | -47.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.50M | -59.09M | -63.32M | 1.15B | -47.26M |
| EBIT | -82.76M | -86.19M | -72.26M | 1.27B | -57.27M |
| EBITDA | -81.23M | -85.80M | -71.13M | 1.27B | -56.57M |
| EPS Basic | -0.86 | -0.84 | -0.90 | 16.29 | -0.67 |
| Normalized Basic EPS | -0.51 | -0.64 | -0.53 | 10.90 | -0.44 |
| EPS Diluted | -0.86 | -0.84 | -0.90 | 16.06 | -0.67 |
| Normalized Diluted EPS | -0.51 | -0.64 | -0.53 | 10.75 | -0.44 |
| Average Basic Shares Outstanding | 70.61M | 70.35M | 70.30M | 70.73M | 70.68M |
| Average Diluted Shares Outstanding | 70.61M | 70.35M | 70.30M | 71.71M | 70.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |